FDA Approved: KLISYRI — Supplemental Application (Almirall, LLC)

View source ↗

Summary

The FDA approved a supplemental application for KLISYRI (tirbanibulin) by Almirall, LLC. This action pertains to the approved NDA 213189.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• KLISYRI (tirbanibulin)

Snippet

SUPPL AP for KLISYRI (TIRBANIBULIN)